Cargando…
Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer
In recent years, diabetes-associated breast cancer has become a significant clinical challenge. Diabetes is not only a risk factor for breast cancer but also worsens its prognosis. Patients with diabetes usually show hyperglycemia and hyperinsulinemia, which are accompanied by different glucose, pro...
Autores principales: | Shum, Hang Chee Erin, Wu, Ke, Vadgama, Jaydutt, Wu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861470/ https://www.ncbi.nlm.nih.gov/pubmed/36675817 http://dx.doi.org/10.3390/jpm13010157 |
Ejemplares similares
-
From Interaction to Intervention: How Mesenchymal Stem Cells Affect and Target Triple-Negative Breast Cancer
por: Wu, Yong, et al.
Publicado: (2023) -
Advancing Cancer Research: Insights and Innovations in Pathogenesis and Targeted Therapies
por: Wu, Yong, et al.
Publicado: (2023) -
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
por: Cao, Wei, et al.
Publicado: (2019) -
A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer
por: Hao, Qiongyu, et al.
Publicado: (2022) -
Celecoxib in breast cancer prevention and therapy
por: Li, Jieqing, et al.
Publicado: (2018)